Cover Image

A combination study design to examine mycophenolate mofetil (MMF) and PTLD in renal transplant patients

Renal transplant recipients who are chronically immunosuppressed by drugs are at a higher risk of developing malignancies. Commonly observed malignancies are several forms of posttransplant lymphoproliferative disorders (PTLD), skin, lip and gynaecological cancers. The risk is associated with many r...

Full description

Saved in:
Bibliographic Details
Main Authors: Maradit Kremers, Hilal (Author) , Funch, Donnie P. (Author) , Robson, Richard A. (Author) , Nalesnik, Michael A. (Author) , Ebrahim, Shah (Author) , Cecka, Michael J. (Author) , Opelz, Gerhard (Author) , Dreyer, Nancy A. (Author) , Walker, Alexander M. (Author)
Format: Article (Journal)
Language:English
Published: 20 January 2000
In: Pharmacoepidemiology and drug safety
Year: 1999, Volume: 8, Issue: 7, Pages: 509-518
ISSN:1099-1557
DOI:10.1002/(SICI)1099-1557(199912)8:7<509::AID-PDS457>3.0.CO;2-1
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1002/(SICI)1099-1557(199912)8:7<509::AID-PDS457>3.0.CO;2-1
Verlag, lizenzpflichtig, Volltext: https://onlinelibrary.wiley.com/doi/10.1002/(SICI)1099-1557(199912)8:7<509::AID-PDS457>3.0.CO;2-1
Get full text
Author Notes:Hilal Maradit Kremers, Donnie P. Funch, Richard A. Robson, Michael A. Nalesnik, Shah Ebrahim, Michael J. Cecka, Gerhard Opelz, Nancy A. Dreyer, Alexander M. Walker
Description
Summary:Renal transplant recipients who are chronically immunosuppressed by drugs are at a higher risk of developing malignancies. Commonly observed malignancies are several forms of posttransplant lymphoproliferative disorders (PTLD), skin, lip and gynaecological cancers. The risk is associated with many risk factors including the extent of immunosuppression. Mycophenolate mofetil (MMF) is an immunosuppressant, indicated for the prophylaxis of organ rejection in patients receiving allogenic renal and heart transplants. During the European approval of MMF for renal transplantation, the question was raised as to whether the use of MMF was associated with an increased risk of PTLD in comparison with alternate immunosuppressive regimens. In response, F. Hoffman-La Roche Ltd set up a prospective observational cohort study with a companion case-control study. This paper describes the objectives and the methods of these studies along with the rationale of the methodology.
Item Description:Gesehen am 19.02.2021
Physical Description:Online Resource
ISSN:1099-1557
DOI:10.1002/(SICI)1099-1557(199912)8:7<509::AID-PDS457>3.0.CO;2-1

Similar Items